Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer

Author：

E-ISSN： 1791-2431|34|1|59-66

ISSN： 1021-335X

Source： Oncology Reports, Vol.34, Iss.1, 2015-01, pp. : 59-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional Expression of Sodium Iodide Symporter (NIS) in Human Breast Cancer Tissue

By Upadhyay G.

Breast Cancer Research and Treatment, Vol. 77, Iss. 2, 2003-01 ,pp. : 157-165

Springer Publishing Company

Access to resources Recommend Favorite

The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)

By Fortunati N. Catalano M. Marano F. Mugoni V. Pugliese M. Bosco O. Mainini F. Boccuzzi G.

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 667-675

Springer Publishing Company

Access to resources Recommend Favorite

131I therapy mediated by sodium/iodide symporter combined with kringle 5 has a synergistic therapeutic effect on glioma

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 691-698

Spandidos Publications

Access to resources Recommend Favorite

The glial fibrillary acidic protein promoter directs sodium/iodide symporter gene expression for radioiodine therapy of malignant glioma

Oncology Letters, Vol. 5, Iss. 2, 2013-01 ,pp. : 669-674

Spandidos Publications

Access to resources Recommend Favorite

AFP Promoter Enhancer Increased Specific Expression of the Human Sodium Iodide Symporter (hNIS) for Targeted Radioiodine Therapy of Hepatocellular Carcinoma

By Ma Xiao-Juan Huang Rui Kuang An-Ren

Cancer Investigation, Vol. 27, Iss. 6, 2009-07 ,pp. : 673-681

Informa Healthcare

Access to resources Recommend Favorite